Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 21 12 2020
revised: 04 03 2021
accepted: 22 03 2021
pubmed: 2 4 2021
medline: 15 5 2021
entrez: 1 4 2021
Statut: ppublish

Résumé

The impact of Covid-19 on the survival of patients presenting with acute coronary syndrome (ACS) remains to be defined. Consecutive patients presenting with ACS at 18 Centers in Northern-Italy during the Covid-19 outbreak were included. In-hospital all-cause death was the primary outcome. In-hospital cardiovascular death along with mechanical and electrical complications were the secondary ones. A case period (February 20, 2020-May 3, 2020) was compared vs. same-year (January 1-February 19, 2020) and previous-year control periods (February 20-May 3, 2019). ACS patients with Covid-19 were further compared with those without. Among 779 ACS patients admitted during the case period, 67 (8.6%) tested positive for Covid-19. In-hospital all-cause mortality was significantly higher during the case period compared to the control periods (6.4% vs. 3.5% vs. 4.4% respectively; p 0.026), but similar after excluding patients with COVID-19 (4.5% vs. 3.5% vs. 4.4%; p 0.73). Cardiovascular mortality was similar between the study groups. After multivariable adjustment, admission for ACS during the COVID-19 outbreak had no impact on in-hospital mortality. In the case period, patients with concomitant ACS and Covid-19 experienced significantly higher in-hospital mortality (25% vs. 5%, p < 0.001) compared to patients without. Moreover, higher rates of cardiovascular death, cardiogenic shock and sustained ventricular tachycardia were found in Covid-19 patients. ACS patients presenting during the Covid-19 pandemic experienced increased all-cause mortality, driven by Covid-19 positive status due to higher rates of cardiogenic shock and sustained ventricular tachycardia. No differences in cardiovascular mortality compared to non-pandemic scenarios were reported.

Identifiants

pubmed: 33794235
pii: S0167-5273(21)00567-2
doi: 10.1016/j.ijcard.2021.03.063
pmc: PMC8006512
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

227-234

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The Authors declare that there is no conflict of interest.

Références

BMJ Evid Based Med. 2021 Dec;26(6):279-284
pubmed: 32788164
Circulation. 2020 Jun 23;141(25):2113-2116
pubmed: 32352306
Eur J Cardiothorac Surg. 2019 Jan 1;55(1):4-90
pubmed: 30165632
Circulation. 2020 Jul 7;142(1):7-9
pubmed: 32286863
Minerva Cardiol Angiol. 2022 Apr;70(2):160-166
pubmed: 32996311
Panminerva Med. 2020 Dec;62(4):252-259
pubmed: 33021366
Heart. 2020 Dec;106(23):1805-1811
pubmed: 32868280
Atherosclerosis. 2018 Jul;274:218-226
pubmed: 29803160
J Am Coll Cardiol. 2020 Sep 8;76(10):1168-1176
pubmed: 32679155
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
Circulation. 2011 Jun 14;123(23):2736-47
pubmed: 21670242
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Int J Cardiol. 2021 Mar 1;326:230-236
pubmed: 32979425
Eur Heart J. 2020 May 14;41(19):1798-1800
pubmed: 32186331
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
J Am Coll Cardiol. 2020 Sep 15;76(11):1318-1324
pubmed: 32828614
JAMA Intern Med. 2021 Feb 1;181(2):279-281
pubmed: 32986117
Eur Heart J. 2019 Jan 14;40(3):237-269
pubmed: 30165617
N Engl J Med. 2020 Jun 18;382(25):2478-2480
pubmed: 32302081
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
EuroIntervention. 2017 Jul 20;13(4):407-414
pubmed: 28169217
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Thromb Haemost. 2020 Dec;120(12):1642-1653
pubmed: 33099284
Minerva Cardioangiol. 2020 Apr;68(2):61-64
pubmed: 32150358
Kidney Int Suppl (2011). 2012 Mar;2(1):19-36
pubmed: 25018918
N Engl J Med. 2019 Oct 10;381(15):1411-1421
pubmed: 31475795

Auteurs

Fabrizio D'Ascenzo (F)

Division of Cardiology, Cardiovascular and Thoracic Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

Ovidio De Filippo (O)

Division of Cardiology, Cardiovascular and Thoracic Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy. Electronic address: odefilippo@cittadellasalute.it.

Andrea Borin (A)

Division of Cardiology, Cardiovascular and Thoracic Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

Lucia Barbieri (L)

Division of Cardiology, ASST Santi Paolo e Carlo, 20142 Milan, Italy.

Marianna Adamo (M)

Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Cardiac Catheterization Laboratory and Cardiology, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

Nuccia Morici (N)

Intensive Cardiac Care Unit and De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Italy.

Alessandra Truffa Giachet (A)

Division of Cardiology, Ospedale "Cardinal Massaia" Asti, Italy.

Mario Iannaccone (M)

Department of Cardiology, Ospedale San G Bosco, Torino, Italy.

Gabriele Crimi (G)

Cardiovascular Disease Unit, Istituto di Ricerca e Cura a Carattere Scientifico Ospedale Policlinico San Martino, IRCCS Italian Cardiology Network, Genova, Italy.

Luca Gaido (L)

Division of Cardiology, Ospedale Maria Vittoria, Torino, Italy.

Pier Paolo Bocchino (PP)

Division of Cardiology, Cardiovascular and Thoracic Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

Carlo Andrea Pivato (CA)

Humanitas Clinical and Research Center IRCCS - Rozzano, Milan, Italy.; Department of Biomedical Sciences - Pieve Emanuele, Humanitas University, Milano, Italy.

Gianluca Campo (G)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Cona, Italy.

Daniela Trabattoni (D)

Invasive Cardiology Unit 3, Centro Cardiologico Monzino, IRCCS, Via Parea, 4 - 20138 Milan, Italy.

Alaide Chieffo (A)

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.

Nicola Gaibazzi (N)

Cardiology Department, Parma University Hospital, Parma, Italy.

Filippo Angelini (F)

Division of Cardiology, Cardiovascular and Thoracic Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

Andrea Rubboli (A)

Division of Cardiology, S Maria delle Croci Hospital, Ravenna, Italy.

Andrea Rognoni (A)

Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.

Giuseppe Musumeci (G)

Cardiology Department, Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Italy.

Fabrizio Ugo (F)

Division of Cardiology, Presidio Ospedaliero Sant'Andrea di Vercelli, Vercelli, Italy.

Sebastiano Gili (S)

Invasive Cardiology Unit 3, Centro Cardiologico Monzino, IRCCS, Via Parea, 4 - 20138 Milan, Italy.

Bernardo Cortese (B)

San Carlo Clinic, Milan, Italy; Fondazione Ricerca e Innovazione Cardiovascolare, Milan, Italy.

Paolo Vadalà (P)

Division of Cardiology, Ospedale Michele e Pietro Ferrero, Verduno, Italy.

Veronica Dusi (V)

Division of Cardiology, Cardiovascular and Thoracic Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

Guglielmo Gallone (G)

Division of Cardiology, Cardiovascular and Thoracic Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

Giuseppe Patti (G)

Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.

Gaetano Maria de Ferrari (GM)

Division of Cardiology, Cardiovascular and Thoracic Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH